Add time:07/23/2019 Source:sciencedirect.com
Summary[(Nα-Me)Leu7]LRF, (pGlu-His-Trp-Ser-Tyr-Gly-(Nα-Me)Leu-Arg-Pro-Gly-NH2), and [D-Ala6,(Na-Me)Leu7]LRF, (pGlu-His-Trp-Ser-Tyr-D-Ala-(Nα-Me) Leu-Arg-Pro-Gly-NH2), were synthesized by solid-phase methodology. The peptides were assayed by the in vitro system against LRF and found to have ca. 102% and 560% the potency of LRF respectively. The biological results are interpreted in terms of the conformational aspects of LRF.
We also recommend Trading Suppliers and Manufacturers of (D-LEU7)-LEUPROLIDE (cas 112710-58-4). Pls Click Website Link as below: cas 112710-58-4 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View